2m 2m 2m 2m 2m 2m 2m
Quantum-Si-A (QSI)
NASDAQ
$1.19-$0.05 (-4.03%)
Price as of Jun 03, 2026 6:48 PM EDT- $235.4MMarket Cap
- -29.55%1-Year Change
- Medical DevicesIndustry
Quantum-Si-A (QSI)
$1.19-$0.05 (-4.03%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.3M -25.25% | 3.1M +182.62% | 1.1M N/A | N/A N/A | |
Cost of Revenue | 1.2M -14.33% | 1.5M +145.45% | 594,000 N/A | N/A N/A | |
Gross Profit | 1.2M -27.94% | 1.6M +227.87% | 488,000 N/A | 0 +100.00% | |
Sales and Marketing Expense | 44.8M -11.44% | 50.5M +13.22% | 44.6M +5.53% | 42.3M +969.16% | |
Research and Development Expense | -53.8M -9.86% | -59.6M -11.02% | -67.0M -6.99% | -72.1M +54.72% | |
Depreciation and Amortization Expense | 4.5M -3.17% | 4.6M +10.68% | 4.2M +60.84% | 2.6M +148.22% | |
Total Operating Expenses | 117.3M +6.42% | 110.2M -1.33% | 111.7M -9.84% | 123.8M +27.79% | |
Operating Profit | -116.1M +6.93% | -108.6M -2.33% | -111.2M -10.23% | -123.8M +27.79% | |
Interest Income | 9.0M -21.13% | 11.4M N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | 0 N/A | 0 +100.00% | |
Interest Income and Expense and Net | 9.0M -21.13% | 11.4M N/A | 0 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | 955,000 +5,126.32% | -19,000 -105.19% | 366,000 +101.82% | -20.1M +302.58% | |
Income before Taxes | -101.3M +0.33% | -101.0M +5.20% | -96.0M -27.55% | -132.4M +39.43% | |
Income Taxes | 58,000 +3.57% | 56,000 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -101.3M +0.33% | -101.0M +5.26% | -96.0M -27.55% | -132.4M +39.43% | |
Net Income from Continuing Operations Applicable to Common | -101.3M +0.33% | -101.0M +5.20% | -96.0M -27.55% | -132.4M +39.43% | |
Basic EPS and Net Income | -0.51 -28.17% | -0.71 +4.41% | -0.68 -28.42% | -0.95 -20.17% | |
Diluted EPS and Net Income | -0.51 -28.17% | -0.71 +4.41% | -0.68 -28.42% | -0.95 -20.17% | |
Basic Weighted Average Shares | 197.8M +38.11% | 143.2M +1.34% | 141.3M +1.47% | 139.3M +74.99% | |
Diluted Weighted Average Shares | 197.8M +38.11% | 143.2M +1.34% | 141.3M +1.47% | 139.3M +74.99% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 21.6M -56.05% | 49.2M -63.21% | 133.9M +58.75% | 84.3M +135.63% | |
Short-Term Investments | 141.3M N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 162.9M +230.84% | 49.2M -63.21% | 133.9M +58.75% | 84.3M -82.11% | |
Total Current Assets | 175.9M -19.33% | 218.0M -18.14% | 266.3M -25.65% | 358.2M -24.94% | |
Accumulated Depreciation | 16.7M +42.97% | 11.7M +16.57% | 10.0M +61.91% | 6.2M +60.08% | |
Property and Plant and Equipment and Net | 13.2M -17.50% | 16.0M -1.73% | 16.3M -3.41% | 16.8M +89.14% | |
Total Long-Term Assets | 234,000 -71.04% | 808,000 +16.26% | 695,000 -0.29% | 697,000 +1.01% | |
Total Assets | 245.6M -0.91% | 247.9M -16.89% | 298.3M -23.82% | 391.5M -22.20% | |
Income Taxes Payable | 549,000 -59.00% | 1.3M N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 70,000 +311.76% | |
Total Current Liabilities | 23.0M +26.60% | 18.2M +56.66% | 11.6M -26.09% | 15.7M +36.24% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 34,000 +78.95% | 19,000 +72.73% | 11,000 N/A | 0 -100.00% | |
Total Liabilities | 25.4M -21.79% | 32.5M +21.85% | 26.6M -18.76% | 32.8M +25.15% | |
Retained Earnings | -698.0M +16.98% | -596.6M +20.38% | -495.6M +24.01% | -399.7M +49.56% | |
Total Stockholders Equity | 220.2M +2.23% | 215.4M -20.69% | 271.6M -24.28% | 358.7M -24.80% | |
Total Shares Outstanding | 196.4M -41.15% | 333.8M +135.44% | 141.8M +1.30% | 139.9M +1.44% | |
Cash Flow | |||||
Cash from Operating Activities | -94.7M +7.88% | -87.8M -6.64% | -94.0M +3.84% | -90.6M +35.54% | |
Capital Expenditures | 2.5M -45.08% | 4.6M +1.62% | 4.5M -58.01% | 10.7M +86.38% | |
Cash from Investing Activities | -28.3M -13.33% | -32.7M -122.78% | 143.4M +4.55% | 137.2M +130.42% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 95.4M +165.98% | 35.9M +23,977.85% | 149,000 -92.19% | 1.9M -99.63% | |
Financials Ratio | |||||
Gross Margin | 45.36% -13.30% | 52.32% +16.01% | 45.10% N/A | N/A N/A | |
Operating Margin | -5,078.70% +43.04% | -3,550.56% -65.44% | -10,274.58% N/A | N/A N/A | |
Return on Assets | -41.07% +11.03% | -36.99% +32.94% | -27.83% -6.01% | -29.61% -3.47% | |
Return on Equity | -46.52% +12.16% | -41.48% +36.23% | -30.45% -3.93% | -31.69% -19.58% | |
Revenue Growth | -25.25% -113.82% | 182.62% N/A | N/A N/A | N/A N/A | |
Current Ratio | 7.64 -36.28% | 11.99 -47.75% | 22.94 +0.59% | 22.81 -44.90% | |
Cash Ratio | 0.94 -65.29% | 2.71 -76.52% | 11.53 +114.78% | 5.37 +72.95% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow